CYTOGENETIC ABNORMALITIES IN POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: CORRELATIONS WITH GENOTYPE AND PHENOTYPE IN THE MYSEC STUDY

被引：0
|
作者：
Mora, B.
Giorgino, T.
Guglielmelli, P.
Rumi, E.
Maffioli, M.
Rambaldi, A.
Caramella, M.
Komrokji, R.
Gotlib, J.
Kiladjian, J. J.
Cervantes, F.
Devos, T.
Palandri, F.
De Stefano, V.
Ruggeri, M.
Silver, R. T.
Benevolo, G.
Albano, F.
Caramazza, D.
Merli, M.
Pietra, D.
Casalone, R.
Barbui, T.
Rotunno, G.
Cazzola, M.
Vannucchi, A. M.
Passamonti, F.
机构：
[1] Univ Insubria, Dept Med & Surg, Hematol, ASST Sette Laghi, Varese, Italy
[2] Univ Florence, Azienda Osped Univ Careggi, Natl Res Council Italy, Inst Neurosci,Dept Expt & Clin Med,CRIMM, Florence, Italy
[3] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy
[4] Univ Insubria, ASST Sette Laghi, Osped Circolo, Dept Med & Surg, Varese, Italy
[5] Univ Milan, Osped Niguarda Ca Granda, ASST Papa Giovanni XXIII, Hematol & BMT Unit, Milan, Italy
[6] Stanford Univ, Moffit Canc Ctr, Stanford, CA 94305 USA
[7] Hop St Louis, St Louis, France
[8] Univ Paris Diderot, Paris, France
[9] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain
[10] Katholieke Univ Leuven, Dept Hematol, Univ Hosp Leuven, Leuven, Belgium
[11] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Expt Transplantat, Leuven, Belgium
[12] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[13] Univ Cattolica Sacro Cuore, Milan, Italy
[14] Osped S Bortolo, Vicenza, Italy
[15] Weill Cornell Med Coll, New York, NY USA
[16] Ctr Oncol Ematol Subalpino COES, Rome, Italy
[17] Univ Bari, Bari, Italy
[18] Osped Circolo Varese, ASST Sette Laghi, Cytogenet & Med Genet Lab, Varese, Italy
[19] Univ Florence, Azienda Osped Univ Careggi, Dept Expt & Clin Med, FROM Res Fdn,ASST Papa Giovanni XXIII,CRIMM, Florence, Italy
[20] Univ Pavia, Dept Hematol Oncol, Fdn IRCCS Policlin San Matteo, Pavia, Italy
[21] Univ Florence, Azienda Osped Univ Careggi, Dept Expt & Clin Med, Ctr Ric & Innovaz Malattie Mieloproliferat, Florence, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B006
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [21] Clinical Phenotype and Genotype Correlations with Time to Progression into Post Polycythemia Vera and Post Essential Thrombocythemia Myelofibrosis
    Mora, Barbara
    Giorgino, Toni
    Guglielmelli, Paola
    Rumi, Elisa
    Maffioli, Margherita
    Caramazza, Domenica
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami
    Gotlib, Jason
    Kiladjian, Jean Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard
    Benevolo, Giulia
    Albano, Francesco
    Merli, Michele
    Pietra, Daniela
    Casalone, Rosario
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro Maria
    Passamonti, Francesco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S354 - S355
  • [22] Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
    Tefferi, A.
    Saeed, L.
    Hanson, C. A.
    Ketterling, R. P.
    Pardanani, A.
    Gangat, N.
    LEUKEMIA, 2017, 31 (12) : 2851 - 2852
  • [23] Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
    Thamer Sliwa
    Christine Beham-Schmid
    Sonja Burgstaller
    Veronika Buxhofer-Ausch
    Günther Gastl
    Klaus Geissler
    Maria Krauth
    Peter Krippl
    Alois Lang
    Andreas Petzer
    Stefan Wöhrer
    Albert Wölfler
    Heinz Gisslinger
    Wiener klinische Wochenschrift, 2017, 129 : 293 - 302
  • [24] Do Patients with Post-Essential Thrombocythemia and Post-Polycythemia Vera Differ from Patients with Primary Myelofibrosis?
    Masarova, Lucia
    Daver, Naval
    Pemmaraju, Naveen
    Bose, Prithviraj
    Pierce, Sherry
    Manshouri, Taghi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    BLOOD, 2015, 126 (23)
  • [25] Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis
    Guy, Alexandre
    Bidet, Audrey
    Ling, Catherine
    Caumont, Charline
    Boureau, Lisa
    Viallard, Jean-Francois
    Parrens, Marie
    VIRCHOWS ARCHIV, 2021, 479 (04) : 755 - 764
  • [26] Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis
    Alexandre Guy
    Audrey Bidet
    Catherine Ling
    Charline Caumont
    Lisa Boureau
    Jean-François Viallard
    Marie Parrens
    Virchows Archiv, 2021, 479 : 755 - 764
  • [27] Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
    Barosi, G.
    Mesa, R. A.
    Thiele, J.
    Cervantes, F.
    Campbell, P. J.
    Verstovsek, S.
    Dupriez, B.
    Levine, R. L.
    Passamonti, F.
    Gotlib, J.
    Reilly, J. T.
    Vannucchi, A. M.
    Hanson, C. A.
    Solberg, L. A.
    Orazi, A.
    Tefferi, A.
    LEUKEMIA, 2008, 22 (02) : 437 - 438
  • [28] Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
    G Barosi
    R A Mesa
    J Thiele
    F Cervantes
    P J Campbell
    S Verstovsek
    B Dupriez
    R L Levine
    F Passamonti
    J Gotlib
    J T Reilly
    A M Vannucchi
    C A Hanson
    L A Solberg
    A Orazi
    A Tefferi
    Leukemia, 2008, 22 : 437 - 438
  • [29] Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study
    Palandri, Francesca
    Palumbo, Giuseppe A.
    Iurlo, Alessandra
    Polverelli, Nicola
    Benevolo, Giulia
    Breccia, Massimo
    Abruzzese, Elisabetta
    Tiribelli, Mario
    Bonifacio, Massimiliano
    Tieghi, Alessia
    Isidori, Alessandro
    Martino, Bruno
    Sgherza, Nicola
    D'Adda, Mariella
    Bergamaschi, Micaela
    Crugnola, Monica
    Cavazzini, Francesco
    Bosi, Costanza
    Binotto, Gianni
    Auteri, Giuseppe
    Latagliata, Roberto
    Ibatici, Adalberto
    Scaffidi, Luigi
    Penna, Domenico
    Cattaneo, Daniele
    Soci, Francesco
    Trawinska, Malgorzata
    Russo, Domenico
    Cuneo, Antonio
    Semenzato, Giampietro
    Di Raimondo, Francesco
    Aversa, Franco
    Lemoli, Roberto M.
    Heidel, Florian
    Reggiani, Maria L. B.
    Bartoletti, Daniela
    Cavo, Michele
    Catani, Lucia
    Vianelli, Nicola
    SEMINARS IN HEMATOLOGY, 2018, 55 (04) : 248 - 255
  • [30] RUXOLITINIB PLUS PANOBINOSTAT IN PATIENTS WITH PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: A PHASE 1B DOSE-FINDING STUDY
    Vannucchi, A. M.
    Heidel, F. H.
    Ribrag, V.
    Kiladjian, J. J.
    Passamonti, F.
    Hayat, A.
    Conneally, E.
    Kindler, T.
    Martino, B.
    Lipka, D. B.
    Acharyya, S.
    Gopalakrishna, P.
    Loechner, S.
    Mu, S.
    Harrison, C. N.
    HAEMATOLOGICA, 2014, 99 : 129 - 130
12345